Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

25%

Ph phase_3

25%

Ph phase_4

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 3Large-scale testing

1(25.0%)

Phase 4Post-market surveillance

2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(2)

Detailed Status

unknown2

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (25.0%)

Phase 31 (25.0%)

Phase 42 (50.0%)

Trials by Status

unknown250%

completed250%

Recent Activity

0 active trials

Showing 4 of 4

unknownphase_4

Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy Persons

NCT05916729

completedphase_1

DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate

NCT01731574

completedphase_3

Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic

NCT02818803

unknownphase_4

Clinical Trial of Hydroquinone Versus Miconazol in Melasma

NCT01661556

Clinical Trials (4)

Showing 4 of 4 trials

NCT05916729Phase 4

Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy Persons

Unknown

NCT01731574Phase 1

DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate

Completed

NCT02818803Phase 3

Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic

Completed

NCT01661556Phase 4

Clinical Trial of Hydroquinone Versus Miconazol in Melasma

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4